Hispanic patients had significantly higher rates of severe cytokine release syndrome.
The confirmed response rate was 27%, and the median progression-free survival was 5.5 months.
Meta-analysis results confirm that women can achieve a successful pregnancy after surviving breast cancer.
Investigators assessed studies for evidence to guide the management of MPN in patients with COVID-19.
Researchers sought to determine whether salvage therapy with high-dose chemotherapy followed by ASCT would improve survival in patients with MM.
Two studies suggest declining effectiveness of the Pfizer-BioNTech COVID-19 vaccine.
The proteins were only predictive for African-American patients, not European-American patients.
Relapse-free survival outcomes were similar between real-world and clinical trial patients.
The approval is based on data from the phase 3 monarchE trial.
The approval was based on data from the phase 3 KEYNOTE-826 trial.